The creators of the risk assessment score say they want to help primary care physicians better identify patients who need extra counseling and follow-up.
Cancer patients increasingly delay or skip taking medication because they can't afford it. New drugs that can cost $100,000 or more a year mean more people suffering "financial toxicity."
Skin lesions are often misdiagnosed as a brown recluse spider bite when they're actually a tick bite or MRSA or even skin cancer. Here's how to tell the difference.
Scanning people at risk for lung cancer finds many nodules that aren't cancerous but prompt more procedures, a study at the VA finds. A small number of people did get their cancer diagnosed early on.
Drugs that have been on the market for decades are being investigated for new uses. One is a medication used around the world to treat pinworm infections.
Scientists have created an experimental device that putters around inside the stomach, neutralizing acid and then delivering antibiotics. The goal is to help the antibiotics work better.
African-American women are more likely to be infected with HIV than other women. So the District of Columbia is launching an effort to inform them about PrEP, medication that can reduce their risk.
We often imagine the best medical care as a miracle cure. Atul Gawande argues that for chronic illness, the best care may be a long, slow process of improving health a little bit at a time.
In 2016, scientists combined the genes of three people in an effort to make a baby free of an inherited disease. But the process doesn't wipe out all faulty mitochondria, and could pose new risks.
Cutting by half the time that children are given antibiotics for ear infections didn't do as good a job, a study finds. And it didn't reduce antibiotic resistance, which was a key goal.
The Federal Trade Commission told purveyors of homeopathic remedies that they have to say there's no scientific evidence that these nostrums actually work. The question is, will fans care?
Medical researchers are no longer ignoring the people who have the most to gain — or lose. But as patient advocates become more influential, they risk being co-opted by the biomedical industry.
Lung cancer affects mostly older people, but they're often not offered surgery as a treatment. A study finds that most older people can tolerate surgery, and that it extends lives.
Scientists are racing to create a vaccine. The latest effort being tested uses inactivated virus, a technique that has been used successfully to fight other diseases, and human volunteers.
Science has failed yet again to come up with hormonal birth control for men. The most recent study was stopped because the men weren't willing to put up with side effects like mood swings and acne.
Nearly every medic in the U.S. military is now trained in San Antonio. Shaped by combat experience in Iraq and Afghanistan, that training has evolved to improve care and save more lives.
Most research on placebos involves people who think they're getting an active treatment, but aren't. But they may also work when people know full well they're getting a sham treatment.
Smartphones can be used to test for atrial fibrillation, a common heart condition that can cause strokes. But it's still not clear who should use this emerging technology.
A Maryland physician teamed up with an environmental scientist to develop a visual approach for helping patients better understand the risks and benefits of medical tests and treatments.
A study finding that using hormonal birth control raises women's risk of depression raised a lot of eyebrows, but also shows how much we still don't know about women's health.
The lack of effective remedies for morning sickness is frustrating, and can mean months of suffering. An obstetrician explains that few medications have been tested for use during early pregnancy.
Almost all women experience morning sickness during pregnancy, but it's hard to figure out what might work when you're busy retching. A review of evidence finds that ginger and acupressure bands help.
Decades ago, a researcher came up with 28 days as the ideal length of stay for inpatient alcoholism rehab, despite lack of evidence that it worked. That model is now being used for opioid addiction.
